ANZUP surveillance recommendations for metastatic testicular cancer post-chemotherapy

These ANZUP recommendations have been developed by ANZUP’s Germ Cell Subcommittee, in accordance with International Germ Cell Consensus Classification, and are provided for use within Australia and New Zealand.

The ANZUP surveillance recommendations for metastatic testicular cancer post-chemotherapy for Metastatic Seminoma – IGCCCG Good / Intermediate Risk, Metastatic Non-Seminoma – IGCCCG Good / Intermediate Risk and Metastatic Non-Seminoma – IGCCCG Poor Intermediate Risk.

These surveillance recommendations are provided as recommendations only. Clinicians should take into account individual circumstances and adaptations may be appropriate. These recommendations do not apply following radiotherapy.

Neither the Germ Cell Subcommittee nor ANZUP shall be liable for any inaccuracies, or adverse outcomes that may occur as a consequence of following these recommendations.

Downloads:

ANZUP surveillance recommendations for metastatic testicular cancer post-chemotherapy